Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal...

Area of Science:

• Urology
• Surgical Oncology
• Renal Cell Carcinoma Research

Background:

• Accurate staging of renal cell carcinoma (RCC) is crucial for patient risk stratification and guiding adjuvant therapy decisions.
• Clinically node-negative RCC patients require precise staging to determine appropriate treatment pathways.

Purpose of the Study:

• To evaluate the feasibility and role of laparoscopic lymph node dissection (LND) in patients undergoing radical nephrectomy for clinically node-negative RCC.
• To assess the impact of LND on staging accuracy and complication rates compared to nephrectomy alone.

Main Methods:

• Retrospective comparison of 50 patients undergoing laparoscopic nephrectomy without LND versus 50 patients with combined laparoscopic nephrectomy and retroperitoneal LND.
• Analysis of clinical, pathological, and oncological outcomes, including nodal status, tumor characteristics, and complication rates.

Main Results:

• No significant differences in clinical or pathological characteristics between groups, except for higher non-clear cell histology in the LND group.
• 10% of patients in the LND group were found to have positive nodes, while none in the nephrectomy-only group did (P=0.0155).
• Positive nodes were associated with larger tumors (≥7 cm), pT3/pT4 stage, and high grade; complication rates were similar between groups.

Conclusions:

• Laparoscopic LND is a safe and feasible procedure for patients undergoing nephrectomy for RCC.
• Laparoscopic LND can enhance staging accuracy in clinically node-negative RCC patients, potentially identifying candidates for further therapy.